Accelerating drug discovery and toxicology studies in biopharma and biotech
Nagi Bioscience’s solutions
Enable biopharma and biotech companies to accelerate drug discovery and toxicology studies using a validated in vivo model that provides high translational value without the ethical concerns of vertebrate models.
Our fully automated, high-throughput system
Offers precise, reproducible data with costs comparable to cell-based assays, making it a practical choice for early-stage compound screening.
By enabling efficient, scalable studies
That de-risk compound selection prior to vertebrate testing, Nagi Bioscience empowers researchers to streamline compound development studies from setup to actionable insights.
De-risk preclinical drug discovery with high-throughput, ethical, in vivo testing models
The pharmaceutical and biotech industries face significant challenges, with lengthy drug discovery cycles and high R&D costs slowing the path to market. Researchers require reliable and high-throughput methods to efficiently screen compounds in vivo earlier in the drug development, reducing time and expense.
Additionally, there is a growing demand for non-animal testing alternatives to align with ethical standards and regulatory pressures, driving the need for innovative, automated solutions that can deliver accurate, reproducible results without relying on traditional animal models.
Automated in vivo results at in vitro scale:
fast, ethical, and cost-effective solutions
Nagi Bioscience sets a new standard in drug discovery by delivering in vivo results at an in vitro scale. Our automated, high-throughput platform allows for rapid preclinical screening without the ethical concerns and high costs associated with traditional animal testing.
By leveraging an in vivo validated models (C. elegans) and real-time, high-content data analysis, we provide researchers with in vivo and reproducible results with high translational value, enabling more accurate predictions of human outcomes earlier in the drug development.
The system’s flexibility supports a broad range of applications, making it a versatile solution for accelerating drug discovery and reducing time to market.
Trusted by
